Esther M. Hoogervorst

433 citations

12 papers · 367 indexed · h-index 10

Co-authors: Harry van Steeg Annemieke de Vries Rudolf B. Beems Conny Th.M. van Oostrom Edwin Zwart Jolanda van den Berg Tyler Jacks S. Wijnhoven
Topics: Cancer-related Molecular Pathways (10 papers)DNA Repair Mechanisms (6 papers)Cancer Research and Treatments (3 papers)
Cited by: Oncology Cancer Research Biotechnology
Journals: Molecular and Cellular Biology Cancer Research Oncogene
Partner nations: Netherlands United States Guinea-Bissau

In The Last Decade

Esther M. Hoogervorst

12 papers receiving 361 citations

Peers

Replace Landon G. Piluso with:

Landon G. Piluso United States

Rachel Amado Bortnick United States

Rachel Zangen United States

Revital Maor-Aloni Israel

Everardo Macías United States

Yue Xiong United States

M Yamada Japan

Charles Dudognon France

An Liao Kuo United States

Esther M. Hoogervorst relative to Landon G. Piluso United States Landon G. Piluso's profile →

Citations per field

00.5×1.5×2.2×

Landon G. Piluso · 1×

×0.6 282/436

MB

×0.9 195/220

ONCOL

×1.6 103/63

CR

×1.4 53/39

CB

×2.2 51/23

BIOTE

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Countries citing papers authored by Esther M. Hoogervorst

Since Specialization

Citations

This map shows the geographic impact of Esther M. Hoogervorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther M. Hoogervorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther M. Hoogervorst more than expected).

Fields of papers citing papers by Esther M. Hoogervorst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther M. Hoogervorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther M. Hoogervorst. The network helps show where Esther M. Hoogervorst may publish in the future.

Co-authorship network of co-authors of Esther M. Hoogervorst

This figure shows the co-authorship network connecting the top 25 collaborators of Esther M. Hoogervorst. A scholar is included among the top collaborators of Esther M. Hoogervorst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther M. Hoogervorst. Esther M. Hoogervorst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Genotoxic exposure: novel cause of selection for a functional ΔN-p53 isoform 2010 ·Oncogene ·(unknown),Esther M. Hoogervorst,Conny Th.M. van Oostrom,Edwin Zwart,Timo M. Breit,Jeroen L. A. Pennings,Annemieke de Vries,Harry van Steeg	8
2	Dominant-Negative but not Gain-of-Function Effects of a p53.R270H Mutation in Mouse Epithelium Tissue after DNA Damage 2007 ·Cancer Research ·S. Wijnhoven,Ewoud N. Speksnijder,Xiaoling Liu,Edwin Zwart,(unknown),Rudolf B. Beems,Esther M. Hoogervorst,Mirjam M. Schaap,Laura D. Attardi,Tyler Jacks,Harry van Steeg,Jos Jonkers,Annemieke de Vries	39
3	Growth stimulation of UV-induced DNA damage retaining epidermal basal cells gives rise to clusters of p53 overexpressing cells 2007 ·DNA repair ·(unknown),(unknown),Ewoud N. Speksnijder,Esther M. Hoogervorst,Leon H.F. Mullenders,Frank R. de Gruijl	7
4	Delayed expression of apoptotic and cell-cycle control genes in carcinogen-exposed bladders of mice lacking p53.S389 phosphorylation 2007 ·Carcinogenesis ·(unknown),Martijs J. Jonker,Oskar Bruning,Jeroen L. A. Pennings,Mirjam M. Schaap,Esther M. Hoogervorst,Harry van Steeg,Timo M. Breit,Annemieke de Vries	10
5	Tissue specific mutagenic and carcinogenic responses in NER defective mouse models 2006 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·S. Wijnhoven,Esther M. Hoogervorst,Harm de Waard,Gijsbertus T. J. van der Horst,Harry van Steeg	52
6	Lack of p53 Ser389 Phosphorylation Predisposes Mice to Develop 2-Acetylaminofluorene–Induced Bladder Tumors but not Ionizing Radiation–Induced Lymphomas 2005 ·Cancer Research ·Esther M. Hoogervorst,(unknown),Edwin Zwart,Conny Th.M. van Oostrom,(unknown),Rudolf B. Beems,Jolanda van den Berg,Tyler Jacks,Harry van Steeg,Annemieke de Vries	29
7	Nucleotide excision repair- and p53-deficient mouse models in cancer research 2005 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Esther M. Hoogervorst,Harry van Steeg,Annemieke de Vries	24
8	2-AAF-induced tumor development in nucleotide excision repair-deficient mice is associated with a defect in global genome repair but not with transcription coupled repair 2004 ·DNA repair ·Esther M. Hoogervorst,Conny Th.M. van Oostrom,Rudolf B. Beems,Jan van Benthem,Jolanda van den Berg,Coen F. van Kreijl,Joseph G. Vos,Annemieke de Vries,Harry van Steeg	21
9	Increased Sensitivity to UV Radiation in Mice with a p53 Point Mutation at Ser389 2004 ·Molecular and Cellular Biology ·(unknown),Edwin Zwart,Laura D. Attardi,Tomoo Iwakuma,Esther M. Hoogervorst,Rudolf B. Beems,Barbara Santos de Miranda,Conny Th.M. van Oostrom,Jolanda van den Berg,(unknown),Guillermina Lozano,Harry van Steeg,Tyler Jacks,Annemieke de Vries	102
10	p53 Heterozygosity Results in an Increased 2-Acetylaminofluorene-Induced Urinary Bladder but not Liver Tumor Response in DNA Repair-Deficient *Xpa* Mice 2004 ·Cancer Research ·Esther M. Hoogervorst,Conny Th.M. van Oostrom,Rudolf B. Beems,Jan van Benthem,(unknown),Jolanda P. Vermeulen,Piet W. Wester,Joseph G. Vos,Annemieke de Vries,Harry van Steeg	18
11	Combined oral benzo[a]pyrene and inhalatory ozone exposure have no effect on lung tumor development in DNA repair-deficient Xpa mice 2003 ·Carcinogenesis ·Esther M. Hoogervorst	19
12	The novel MMS‐inducible gene Mif1/KIAA0025 is a target of the unfolded protein response pathway 2000 ·FEBS Letters ·Theo van Laar,Theo Schouten,Esther M. Hoogervorst,(unknown),Alex J. van der Eb,Carrol Terleth	38

About Esther M. Hoogervorst

Esther M. Hoogervorst is a scholar working on Oncology, Biotechnology and Cancer Research, having authored 12 papers that have together received 367 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (10 papers), DNA Repair Mechanisms (6 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Oncology (195 citations), Cancer Research (103 citations) and Biotechnology (51 citations). Esther M. Hoogervorst has collaborated with scholars based in Netherlands, United States and Guinea-Bissau. Frequent co-authors include Harry van Steeg, Annemieke de Vries, Rudolf B. Beems, Conny Th.M. van Oostrom, Edwin Zwart, Jolanda van den Berg, Tyler Jacks, S. Wijnhoven, Laura D. Attardi and Gijsbertus T. J. van der Horst. Their work appears in journals such as Molecular and Cellular Biology, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact